The group’s principle activity is to manufacture solid and semi-solid dosage forms for Clinical Trial Materials and commercial manufacturing. The group also provides analytical services that fully support formulation development and manufacturing at a ratio of four to one analytical chemists to formulators. The group operates from United States.
